Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Human Fibroblast Growth Factor Market Research Report 2025
Global Human Fibroblast Growth Factor Market Research Report 2025
Industry: Medical Devices & Consumables
Published Date: 2025-03-10
Pages: 90 Pages
Report ld: 4613021
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Human Fibroblast Growth Factor Market Size(US$)
CAGR 2025-2031
4.5%
Market Size,2031
USD 141
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 108 million
Market Forecast in 2031(Value)
US$ 141 million
CAGR
4.5%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Human Fibroblast Growth Factor was valued at US$ 104 million in the year 2024 and is projected to reach a revised size of US$ 141 million by 2031, growing at a CAGR of 4.5% during the forecast period.
Recombinant human fibroblast growth factor is a heparin-binding mitogenic protein that promotes the proliferation of a variety of cells under serum-free or reduced serum conditions. 1/pack, formerly catalog number 40060. This growth factor can be used to promote long-term proliferation of cultured cells and to induce differentiation of a variety of cells under serum-free or reduced serum conditions.
North American market for Human Fibroblast Growth Factor is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Human Fibroblast Growth Factor is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Human Fibroblast Growth Factor include STEMCELL, Merck, YEASEN, BPS Bioscience, R&D Systems, Inc., Thermo Fisher Scientific Inc., Cell Guidance Systems LLC, Abcam Limited, ACROBiosystems, Proteintech Group, Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Human Fibroblast Growth Factor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Fibroblast Growth Factor.
The Human Fibroblast Growth Factor market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Fibroblast Growth Factor market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Fibroblast Growth Factor manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
STEMCELL
Merck
YEASEN
BPS Bioscience
R&D Systems, Inc.
Thermo Fisher Scientific Inc.
Cell Guidance Systems LLC
Abcam Limited
ACROBiosystems
Proteintech Group, Inc
BioLegend, Inc
InVitria
Sinobiological
Segment by Type
Purity < 97%
Purity ≥ 97%
Segment by Application
Laboratory
University
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Fibroblast Growth Factor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Fibroblast Growth Factor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Human Fibroblast Growth Factor Market Overview
1.1 Product Definition
1.2 Human Fibroblast Growth Factor by Type
1.2.1 Global Human Fibroblast Growth Factor Market Value Comparison by Type (2024 VS 2031)
1.2.2 Purity < 97%
1.2.3 Purity ≥ 97%
1.3 Human Fibroblast Growth Factor by Application
1.3.1 Global Human Fibroblast Growth Factor Market Value by Application (2024 VS 2031)
1.3.2 Laboratory
1.3.3 University
1.3.4 Others
1.4 Global Human Fibroblast Growth Factor Market Size Estimates and Forecasts
1.4.1 Global Human Fibroblast Growth Factor Revenue 2020-2031
1.4.2 Global Human Fibroblast Growth Factor Sales 2020-2031
1.4.3 Global Human Fibroblast Growth Factor Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Human Fibroblast Growth Factor Market Competition by Manufacturers
2.1 Global Human Fibroblast Growth Factor Sales Market Share by Manufacturers (2020-2025)
2.2 Global Human Fibroblast Growth Factor Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Human Fibroblast Growth Factor Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Human Fibroblast Growth Factor, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Fibroblast Growth Factor, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Fibroblast Growth Factor, Product Type & Application
2.7 Global Key Manufacturers of Human Fibroblast Growth Factor, Date of Enter into This Industry
2.8 Global Human Fibroblast Growth Factor Market Competitive Situation and Trends
2.8.1 Global Human Fibroblast Growth Factor Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Human Fibroblast Growth Factor Players Market Share by Revenue
2.8.3 Global Human Fibroblast Growth Factor Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human Fibroblast Growth Factor Market Scenario by Region
3.1 Global Human Fibroblast Growth Factor Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Human Fibroblast Growth Factor Sales by Region: 2020-2031
3.2.1 Global Human Fibroblast Growth Factor Sales by Region: 2020-2025
3.2.2 Global Human Fibroblast Growth Factor Sales by Region: 2026-2031
3.3 Global Human Fibroblast Growth Factor Revenue by Region: 2020-2031
3.3.1 Global Human Fibroblast Growth Factor Revenue by Region: 2020-2025
3.3.2 Global Human Fibroblast Growth Factor Revenue by Region: 2026-2031
3.4 North America Human Fibroblast Growth Factor Market Facts & Figures by Country
3.4.1 North America Human Fibroblast Growth Factor Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Human Fibroblast Growth Factor Sales by Country (2020-2031)
3.4.3 North America Human Fibroblast Growth Factor Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Fibroblast Growth Factor Market Facts & Figures by Country
3.5.1 Europe Human Fibroblast Growth Factor Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Human Fibroblast Growth Factor Sales by Country (2020-2031)
3.5.3 Europe Human Fibroblast Growth Factor Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Fibroblast Growth Factor Market Facts & Figures by Region
3.6.1 Asia Pacific Human Fibroblast Growth Factor Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Human Fibroblast Growth Factor Sales by Region (2020-2031)
3.6.3 Asia Pacific Human Fibroblast Growth Factor Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Human Fibroblast Growth Factor Market Facts & Figures by Country
3.7.1 Latin America Human Fibroblast Growth Factor Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Human Fibroblast Growth Factor Sales by Country (2020-2031)
3.7.3 Latin America Human Fibroblast Growth Factor Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Human Fibroblast Growth Factor Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Fibroblast Growth Factor Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Human Fibroblast Growth Factor Sales by Country (2020-2031)
3.8.3 Middle East and Africa Human Fibroblast Growth Factor Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Fibroblast Growth Factor Sales by Type (2020-2031)
4.1.1 Global Human Fibroblast Growth Factor Sales by Type (2020-2025)
4.1.2 Global Human Fibroblast Growth Factor Sales by Type (2026-2031)
4.1.3 Global Human Fibroblast Growth Factor Sales Market Share by Type (2020-2031)
4.2 Global Human Fibroblast Growth Factor Revenue by Type (2020-2031)
4.2.1 Global Human Fibroblast Growth Factor Revenue by Type (2020-2025)
4.2.2 Global Human Fibroblast Growth Factor Revenue by Type (2026-2031)
4.2.3 Global Human Fibroblast Growth Factor Revenue Market Share by Type (2020-2031)
4.3 Global Human Fibroblast Growth Factor Price by Type (2020-2031)
5 Segment by Application
5.1 Global Human Fibroblast Growth Factor Sales by Application (2020-2031)
5.1.1 Global Human Fibroblast Growth Factor Sales by Application (2020-2025)
5.1.2 Global Human Fibroblast Growth Factor Sales by Application (2026-2031)
5.1.3 Global Human Fibroblast Growth Factor Sales Market Share by Application (2020-2031)
5.2 Global Human Fibroblast Growth Factor Revenue by Application (2020-2031)
5.2.1 Global Human Fibroblast Growth Factor Revenue by Application (2020-2025)
5.2.2 Global Human Fibroblast Growth Factor Revenue by Application (2026-2031)
5.2.3 Global Human Fibroblast Growth Factor Revenue Market Share by Application (2020-2031)
5.3 Global Human Fibroblast Growth Factor Price by Application (2020-2031)
6 Key Companies Profiled
6.1 STEMCELL
6.1.1 STEMCELL Company Information
6.1.2 STEMCELL Description and Business Overview
6.1.3 STEMCELL Human Fibroblast Growth Factor Sales, Revenue and Gross Margin (2020-2025)
6.1.4 STEMCELL Human Fibroblast Growth Factor Product Portfolio
6.1.5 STEMCELL Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Human Fibroblast Growth Factor Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck Human Fibroblast Growth Factor Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 YEASEN
6.3.1 YEASEN Company Information
6.3.2 YEASEN Description and Business Overview
6.3.3 YEASEN Human Fibroblast Growth Factor Sales, Revenue and Gross Margin (2020-2025)
6.3.4 YEASEN Human Fibroblast Growth Factor Product Portfolio
6.3.5 YEASEN Recent Developments/Updates
6.4 BPS Bioscience
6.4.1 BPS Bioscience Company Information
6.4.2 BPS Bioscience Description and Business Overview
6.4.3 BPS Bioscience Human Fibroblast Growth Factor Sales, Revenue and Gross Margin (2020-2025)
6.4.4 BPS Bioscience Human Fibroblast Growth Factor Product Portfolio
6.4.5 BPS Bioscience Recent Developments/Updates
6.5 R&D Systems, Inc.
6.5.1 R&D Systems, Inc. Company Information
6.5.2 R&D Systems, Inc. Description and Business Overview
6.5.3 R&D Systems, Inc. Human Fibroblast Growth Factor Sales, Revenue and Gross Margin (2020-2025)
6.5.4 R&D Systems, Inc. Human Fibroblast Growth Factor Product Portfolio
6.5.5 R&D Systems, Inc. Recent Developments/Updates
6.6 Thermo Fisher Scientific Inc.
6.6.1 Thermo Fisher Scientific Inc. Company Information
6.6.2 Thermo Fisher Scientific Inc. Description and Business Overview
6.6.3 Thermo Fisher Scientific Inc. Human Fibroblast Growth Factor Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Thermo Fisher Scientific Inc. Human Fibroblast Growth Factor Product Portfolio
6.6.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
6.7 Cell Guidance Systems LLC
6.7.1 Cell Guidance Systems LLC Company Information
6.7.2 Cell Guidance Systems LLC Description and Business Overview
6.7.3 Cell Guidance Systems LLC Human Fibroblast Growth Factor Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Cell Guidance Systems LLC Human Fibroblast Growth Factor Product Portfolio
6.7.5 Cell Guidance Systems LLC Recent Developments/Updates
6.8 Abcam Limited
6.8.1 Abcam Limited Company Information
6.8.2 Abcam Limited Description and Business Overview
6.8.3 Abcam Limited Human Fibroblast Growth Factor Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Abcam Limited Human Fibroblast Growth Factor Product Portfolio
6.8.5 Abcam Limited Recent Developments/Updates
6.9 ACROBiosystems
6.9.1 ACROBiosystems Company Information
6.9.2 ACROBiosystems Description and Business Overview
6.9.3 ACROBiosystems Human Fibroblast Growth Factor Sales, Revenue and Gross Margin (2020-2025)
6.9.4 ACROBiosystems Human Fibroblast Growth Factor Product Portfolio
6.9.5 ACROBiosystems Recent Developments/Updates
6.10 Proteintech Group, Inc
6.10.1 Proteintech Group, Inc Company Information
6.10.2 Proteintech Group, Inc Description and Business Overview
6.10.3 Proteintech Group, Inc Human Fibroblast Growth Factor Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Proteintech Group, Inc Human Fibroblast Growth Factor Product Portfolio
6.10.5 Proteintech Group, Inc Recent Developments/Updates
6.11 BioLegend, Inc
6.11.1 BioLegend, Inc Company Information
6.11.2 BioLegend, Inc Description and Business Overview
6.11.3 BioLegend, Inc Human Fibroblast Growth Factor Sales, Revenue and Gross Margin (2020-2025)
6.11.4 BioLegend, Inc Human Fibroblast Growth Factor Product Portfolio
6.11.5 BioLegend, Inc Recent Developments/Updates
6.12 InVitria
6.12.1 InVitria Company Information
6.12.2 InVitria Description and Business Overview
6.12.3 InVitria Human Fibroblast Growth Factor Sales, Revenue and Gross Margin (2020-2025)
6.12.4 InVitria Human Fibroblast Growth Factor Product Portfolio
6.12.5 InVitria Recent Developments/Updates
6.13 Sinobiological
6.13.1 Sinobiological Company Information
6.13.2 Sinobiological Description and Business Overview
6.13.3 Sinobiological Human Fibroblast Growth Factor Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Sinobiological Human Fibroblast Growth Factor Product Portfolio
6.13.5 Sinobiological Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Fibroblast Growth Factor Industry Chain Analysis
7.2 Human Fibroblast Growth Factor Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Fibroblast Growth Factor Production Mode & Process Analysis
7.4 Human Fibroblast Growth Factor Sales and Marketing
7.4.1 Human Fibroblast Growth Factor Sales Channels
7.4.2 Human Fibroblast Growth Factor Distributors
7.5 Human Fibroblast Growth Factor Customer Analysis
8 Human Fibroblast Growth Factor Market Dynamics
8.1 Human Fibroblast Growth Factor Industry Trends
8.2 Human Fibroblast Growth Factor Market Drivers
8.3 Human Fibroblast Growth Factor Market Challenges
8.4 Human Fibroblast Growth Factor Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Human Fibroblast Growth Factor Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Human Fibroblast Growth Factor Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Human Fibroblast Growth Factor Market Competitive Situation by Manufacturers in 2024
Table 4. Global Human Fibroblast Growth Factor Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Human Fibroblast Growth Factor Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Human Fibroblast Growth Factor Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Human Fibroblast Growth Factor Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Human Fibroblast Growth Factor Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Human Fibroblast Growth Factor, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Human Fibroblast Growth Factor, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Human Fibroblast Growth Factor, Product Type & Application
Table 12. Global Key Manufacturers of Human Fibroblast Growth Factor, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Fibroblast Growth Factor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Fibroblast Growth Factor as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Fibroblast Growth Factor Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Human Fibroblast Growth Factor Sales by Region (2020-2025) & (K Units)
Table 18. Global Human Fibroblast Growth Factor Sales Market Share by Region (2020-2025)
Table 19. Global Human Fibroblast Growth Factor Sales by Region (2026-2031) & (K Units)
Table 20. Global Human Fibroblast Growth Factor Sales Market Share by Region (2026-2031)
Table 21. Global Human Fibroblast Growth Factor Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Human Fibroblast Growth Factor Revenue Market Share by Region (2020-2025)
Table 23. Global Human Fibroblast Growth Factor Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Human Fibroblast Growth Factor Revenue Market Share by Region (2026-2031)
Table 25. North America Human Fibroblast Growth Factor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Human Fibroblast Growth Factor Sales by Country (2020-2025) & (K Units)
Table 27. North America Human Fibroblast Growth Factor Sales by Country (2026-2031) & (K Units)
Table 28. North America Human Fibroblast Growth Factor Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Human Fibroblast Growth Factor Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Human Fibroblast Growth Factor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Human Fibroblast Growth Factor Sales by Country (2020-2025) & (K Units)
Table 32. Europe Human Fibroblast Growth Factor Sales by Country (2026-2031) & (K Units)
Table 33. Europe Human Fibroblast Growth Factor Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Human Fibroblast Growth Factor Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Human Fibroblast Growth Factor Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Human Fibroblast Growth Factor Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Human Fibroblast Growth Factor Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Human Fibroblast Growth Factor Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Human Fibroblast Growth Factor Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Human Fibroblast Growth Factor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Human Fibroblast Growth Factor Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Human Fibroblast Growth Factor Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Human Fibroblast Growth Factor Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Human Fibroblast Growth Factor Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Human Fibroblast Growth Factor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Human Fibroblast Growth Factor Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Human Fibroblast Growth Factor Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Human Fibroblast Growth Factor Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Human Fibroblast Growth Factor Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Human Fibroblast Growth Factor Sales (K Units) by Type (2020-2025)
Table 51. Global Human Fibroblast Growth Factor Sales (K Units) by Type (2026-2031)
Table 52. Global Human Fibroblast Growth Factor Sales Market Share by Type (2020-2025)
Table 53. Global Human Fibroblast Growth Factor Sales Market Share by Type (2026-2031)
Table 54. Global Human Fibroblast Growth Factor Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Human Fibroblast Growth Factor Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Human Fibroblast Growth Factor Revenue Market Share by Type (2020-2025)
Table 57. Global Human Fibroblast Growth Factor Revenue Market Share by Type (2026-2031)
Table 58. Global Human Fibroblast Growth Factor Price (US$/Unit) by Type (2020-2025)
Table 59. Global Human Fibroblast Growth Factor Price (US$/Unit) by Type (2026-2031)
Table 60. Global Human Fibroblast Growth Factor Sales (K Units) by Application (2020-2025)
Table 61. Global Human Fibroblast Growth Factor Sales (K Units) by Application (2026-2031)
Table 62. Global Human Fibroblast Growth Factor Sales Market Share by Application (2020-2025)
Table 63. Global Human Fibroblast Growth Factor Sales Market Share by Application (2026-2031)
Table 64. Global Human Fibroblast Growth Factor Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Human Fibroblast Growth Factor Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Human Fibroblast Growth Factor Revenue Market Share by Application (2020-2025)
Table 67. Global Human Fibroblast Growth Factor Revenue Market Share by Application (2026-2031)
Table 68. Global Human Fibroblast Growth Factor Price (US$/Unit) by Application (2020-2025)
Table 69. Global Human Fibroblast Growth Factor Price (US$/Unit) by Application (2026-2031)
Table 70. STEMCELL Company Information
Table 71. STEMCELL Description and Business Overview
Table 72. STEMCELL Human Fibroblast Growth Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. STEMCELL Human Fibroblast Growth Factor Product
Table 74. STEMCELL Recent Developments/Updates
Table 75. Merck Company Information
Table 76. Merck Description and Business Overview
Table 77. Merck Human Fibroblast Growth Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Merck Human Fibroblast Growth Factor Product
Table 79. Merck Recent Developments/Updates
Table 80. YEASEN Company Information
Table 81. YEASEN Description and Business Overview
Table 82. YEASEN Human Fibroblast Growth Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. YEASEN Human Fibroblast Growth Factor Product
Table 84. YEASEN Recent Developments/Updates
Table 85. BPS Bioscience Company Information
Table 86. BPS Bioscience Description and Business Overview
Table 87. BPS Bioscience Human Fibroblast Growth Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. BPS Bioscience Human Fibroblast Growth Factor Product
Table 89. BPS Bioscience Recent Developments/Updates
Table 90. R&D Systems, Inc. Company Information
Table 91. R&D Systems, Inc. Description and Business Overview
Table 92. R&D Systems, Inc. Human Fibroblast Growth Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. R&D Systems, Inc. Human Fibroblast Growth Factor Product
Table 94. R&D Systems, Inc. Recent Developments/Updates
Table 95. Thermo Fisher Scientific Inc. Company Information
Table 96. Thermo Fisher Scientific Inc. Description and Business Overview
Table 97. Thermo Fisher Scientific Inc. Human Fibroblast Growth Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Thermo Fisher Scientific Inc. Human Fibroblast Growth Factor Product
Table 99. Thermo Fisher Scientific Inc. Recent Developments/Updates
Table 100. Cell Guidance Systems LLC Company Information
Table 101. Cell Guidance Systems LLC Description and Business Overview
Table 102. Cell Guidance Systems LLC Human Fibroblast Growth Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Cell Guidance Systems LLC Human Fibroblast Growth Factor Product
Table 104. Cell Guidance Systems LLC Recent Developments/Updates
Table 105. Abcam Limited Company Information
Table 106. Abcam Limited Description and Business Overview
Table 107. Abcam Limited Human Fibroblast Growth Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Abcam Limited Human Fibroblast Growth Factor Product
Table 109. Abcam Limited Recent Developments/Updates
Table 110. ACROBiosystems Company Information
Table 111. ACROBiosystems Description and Business Overview
Table 112. ACROBiosystems Human Fibroblast Growth Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. ACROBiosystems Human Fibroblast Growth Factor Product
Table 114. ACROBiosystems Recent Developments/Updates
Table 115. Proteintech Group, Inc Company Information
Table 116. Proteintech Group, Inc Description and Business Overview
Table 117. Proteintech Group, Inc Human Fibroblast Growth Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Proteintech Group, Inc Human Fibroblast Growth Factor Product
Table 119. Proteintech Group, Inc Recent Developments/Updates
Table 120. BioLegend, Inc Company Information
Table 121. BioLegend, Inc Description and Business Overview
Table 122. BioLegend, Inc Human Fibroblast Growth Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. BioLegend, Inc Human Fibroblast Growth Factor Product
Table 124. BioLegend, Inc Recent Developments/Updates
Table 125. InVitria Company Information
Table 126. InVitria Description and Business Overview
Table 127. InVitria Human Fibroblast Growth Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. InVitria Human Fibroblast Growth Factor Product
Table 129. InVitria Recent Developments/Updates
Table 130. Sinobiological Company Information
Table 131. Sinobiological Description and Business Overview
Table 132. Sinobiological Human Fibroblast Growth Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Sinobiological Human Fibroblast Growth Factor Product
Table 134. Sinobiological Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Human Fibroblast Growth Factor Distributors List
Table 138. Human Fibroblast Growth Factor Customers List
Table 139. Human Fibroblast Growth Factor Market Trends
Table 140. Human Fibroblast Growth Factor Market Drivers
Table 141. Human Fibroblast Growth Factor Market Challenges
Table 142. Human Fibroblast Growth Factor Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Human Fibroblast Growth Factor
Figure 2. Global Human Fibroblast Growth Factor Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Human Fibroblast Growth Factor Market Share by Type: 2024 & 2031
Figure 4. Purity < 97% Product Picture
Figure 5. Purity ≥ 97% Product Picture
Figure 6. Global Human Fibroblast Growth Factor Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Human Fibroblast Growth Factor Market Share by Application: 2024 & 2031
Figure 8. Laboratory
Figure 9. University
Figure 10. Others
Figure 11. Global Human Fibroblast Growth Factor Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Human Fibroblast Growth Factor Market Size (2020-2031) & (US$ Million)
Figure 13. Global Human Fibroblast Growth Factor Sales (2020-2031) & (K Units)
Figure 14. Global Human Fibroblast Growth Factor Average Price (US$/Unit) & (2020-2031)
Figure 15. Human Fibroblast Growth Factor Report Years Considered
Figure 16. Human Fibroblast Growth Factor Sales Share by Manufacturers in 2024
Figure 17. Global Human Fibroblast Growth Factor Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Human Fibroblast Growth Factor Players: Market Share by Revenue in Human Fibroblast Growth Factor in 2024
Figure 19. Human Fibroblast Growth Factor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Human Fibroblast Growth Factor Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Human Fibroblast Growth Factor Sales Market Share by Country (2020-2031)
Figure 22. North America Human Fibroblast Growth Factor Revenue Market Share by Country (2020-2031)
Figure 23. United States Human Fibroblast Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Human Fibroblast Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Human Fibroblast Growth Factor Sales Market Share by Country (2020-2031)
Figure 26. Europe Human Fibroblast Growth Factor Revenue Market Share by Country (2020-2031)
Figure 27. Germany Human Fibroblast Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Human Fibroblast Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Human Fibroblast Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Human Fibroblast Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Human Fibroblast Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Human Fibroblast Growth Factor Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Human Fibroblast Growth Factor Revenue Market Share by Region (2020-2031)
Figure 34. China Human Fibroblast Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Human Fibroblast Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Human Fibroblast Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Human Fibroblast Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Human Fibroblast Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Human Fibroblast Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Human Fibroblast Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Human Fibroblast Growth Factor Sales Market Share by Country (2020-2031)
Figure 42. Latin America Human Fibroblast Growth Factor Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Human Fibroblast Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Human Fibroblast Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Human Fibroblast Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Colombia Human Fibroblast Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Human Fibroblast Growth Factor Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Human Fibroblast Growth Factor Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Human Fibroblast Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Human Fibroblast Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Human Fibroblast Growth Factor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Human Fibroblast Growth Factor by Type (2020-2031)
Figure 53. Global Revenue Market Share of Human Fibroblast Growth Factor by Type (2020-2031)
Figure 54. Global Human Fibroblast Growth Factor Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Human Fibroblast Growth Factor by Application (2020-2031)
Figure 56. Global Revenue Market Share of Human Fibroblast Growth Factor by Application (2020-2031)
Figure 57. Global Human Fibroblast Growth Factor Price (US$/Unit) by Application (2020-2031)
Figure 58. Human Fibroblast Growth Factor Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Human Fibroblast Growth Factor market size from 2025 to 2031?
The annual compound growth rate of the global Human Fibroblast Growth Factor market is 4.5% 2025 to 2031.
Which region is expected to have the highest market share?
What was the global market size of Human Fibroblast Growth Factor in 2025?
What was the global market size of Human Fibroblast Growth Factor in 2031?
Which companies rank high in the global Human Fibroblast Growth Factor market?
Related Reports
Global Human Fibroblast Growth Factor Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Human Fibroblast Growth Factor market is projected to grow from US$ 108 million in 2025 to US$ 147 million by 2032, at a CAGR of 4.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-25
Pages: 166
USD 4900.00
(Single User License)
Global Human Fibroblast Growth Factor Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Human Fibroblast Growth Factor market size was US$ 108 million in 2025 and is forecast to reach a readjusted size of US$ 147 million by 2032 with a CAGR of 4.5% during the forecast period 2026-2032.
Published Date: 2026-03-25
Pages: 92
USD 4250.00
(Single User License)
Global Human Fibroblast Growth Factor Market Research Report 2026
The global Human Fibroblast Growth Factor market was valued at US$ 108 million in 2025 and is anticipated to reach US$ 147 million by 2032, at a CAGR of 4.5% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 127
USD 2900.00
(Single User License)
Human Fibroblast Growth Factor- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Human Fibroblast Growth Factor was estimated to be worth US$ 108 million in 2025 and is projected to reach US$ 147 million, growing at a CAGR of 4.5% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 123
USD 3950.00
(Single User License)
Global Human Fibroblast Growth Factor Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Human Fibroblast Growth Factor market size was US$ 104 million in 2024 and is forecast to a readjusted size of US$ 141 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 98
USD 4250.00
(Single User License)
Global Human Fibroblast Growth Factor Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Human Fibroblast Growth Factor market is projected to grow from US$ 104 million in 2024 to US$ 141 million by 2031, at a CAGR of 4.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-01
Pages: 153
USD 4900.00
(Single User License)
Human Fibroblast Growth Factor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Human Fibroblast Growth Factor was estimated to be worth US$ 104 million in 2024 and is forecast to a readjusted size of US$ 141 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 111
USD 3950.00
(Single User License)
Global Human Fibroblast Growth Factor Market Insights, Forecast to 2030
The global Human Fibroblast Growth Factor market is projected to grow from US$ 104 million in 2024 to US$ 135 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.5% during the forecast period.
Published Date: 2024-11-15
Pages: 157
USD 4900.00
(Single User License)
Global and United States Human Fibroblast Growth Factor Market Report & Forecast 2024-2030
The global Human Fibroblast Growth Factor revenue was US$ 98 million in 2023 and is forecast to a readjusted size of US$ 135 million by 2030 with a CAGR of 4.5% during the review period (2024-2030).
Published Date: 2024-11-15
Pages: 137
USD 4350.00
(Single User License)
Human Fibroblast Growth Factor- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Human Fibroblast Growth Factor was estimated to be worth US$ 98 million in 2023 and is forecast to a readjusted size of US$ 135 million by 2030 with a CAGR of 4.5% during the forecast period 2024-2030.
Published Date: 2024-11-15
Pages: 117
USD 3950.00
(Single User License)
Global Human Fibroblast Growth Factor Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Human Fibroblast Growth Factor market is projected to grow from US$ 108 million in 2025 to US$ 147 million by 2032, at a CAGR of 4.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-25
Pages: 166
USD 4900.00 (Single User License)Global Human Fibroblast Growth Factor Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Human Fibroblast Growth Factor market size was US$ 108 million in 2025 and is forecast to reach a readjusted size of US$ 147 million by 2032 with a CAGR of 4.5% during the forecast period 2026-2032.
Published: 2026-03-25
Pages: 92
USD 4250.00 (Single User License)Global Human Fibroblast Growth Factor Market Research Report 2026
The global Human Fibroblast Growth Factor market was valued at US$ 108 million in 2025 and is anticipated to reach US$ 147 million by 2032, at a CAGR of 4.5% from 2026 to 2032.
Published: 2026-01-08
Pages: 127
USD 2900.00 (Single User License)Human Fibroblast Growth Factor- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Human Fibroblast Growth Factor was estimated to be worth US$ 108 million in 2025 and is projected to reach US$ 147 million, growing at a CAGR of 4.5% from 2026 to 2032.
Published: 2026-01-08
Pages: 123
USD 3950.00 (Single User License)Global Human Fibroblast Growth Factor Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Human Fibroblast Growth Factor market size was US$ 104 million in 2024 and is forecast to a readjusted size of US$ 141 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 98
USD 4250.00 (Single User License)Global Human Fibroblast Growth Factor Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Human Fibroblast Growth Factor market is projected to grow from US$ 104 million in 2024 to US$ 141 million by 2031, at a CAGR of 4.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-01
Pages: 153
USD 4900.00 (Single User License)Human Fibroblast Growth Factor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Human Fibroblast Growth Factor was estimated to be worth US$ 104 million in 2024 and is forecast to a readjusted size of US$ 141 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 111
USD 3950.00 (Single User License)Global Human Fibroblast Growth Factor Market Insights, Forecast to 2030
The global Human Fibroblast Growth Factor market is projected to grow from US$ 104 million in 2024 to US$ 135 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.5% during the forecast period.
Published: 2024-11-15
Pages: 157
USD 4900.00 (Single User License)Global and United States Human Fibroblast Growth Factor Market Report & Forecast 2024-2030
The global Human Fibroblast Growth Factor revenue was US$ 98 million in 2023 and is forecast to a readjusted size of US$ 135 million by 2030 with a CAGR of 4.5% during the review period (2024-2030).
Published: 2024-11-15
Pages: 137
USD 4350.00 (Single User License)Human Fibroblast Growth Factor- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Human Fibroblast Growth Factor was estimated to be worth US$ 98 million in 2023 and is forecast to a readjusted size of US$ 135 million by 2030 with a CAGR of 4.5% during the forecast period 2024-2030.
Published: 2024-11-15
Pages: 117
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now